LEGN logo

Legend Biotech Corporation (LEGN) EBIT

Annual EBIT:

-$309.57M+$132.65M(+30.00%)
December 31, 2024

Summary

  • As of today, LEGN annual earnings before interest & taxes is -$309.57 million, with the most recent change of +$132.65 million (+30.00%) on December 31, 2024.
  • During the last 3 years, LEGN annual EBIT has risen by +$84.43 million (+21.43%).
  • LEGN annual EBIT is now -2346.36% below its all-time high of $13.78 million, reached on December 1, 2017.

Performance

LEGN EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLEGNincome statement metrics

Quarterly EBIT:

-$43.51M-$21.55M(-98.15%)
September 30, 2025

Summary

  • As of today, LEGN quarterly earnings before interest & taxes is -$43.51 million, with the most recent change of -$21.55 million (-98.15%) on September 30, 2025.
  • Over the past year, LEGN quarterly EBIT has increased by +$26.85 million (+38.16%).
  • LEGN quarterly EBIT is now -251.11% below its all-time high of -$12.39 million, reached on March 31, 2019.

Performance

LEGN Quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLEGNincome statement metrics

TTM EBIT:

-$195.21M+$26.85M(+12.09%)
September 30, 2025

Summary

  • As of today, LEGN TTM earnings before interest & taxes is -$195.21 million, with the most recent change of +$26.85 million (+12.09%) on September 30, 2025.
  • Over the past year, LEGN TTM EBIT has increased by +$156.03 million (+44.42%).
  • LEGN TTM EBIT is now -1475.30% below its all-time high of -$12.39 million, reached on March 31, 2019.

Performance

LEGN TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLEGNincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

LEGN EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+30.0%+38.2%+44.4%
3Y3 Years+21.4%+69.9%+56.3%
5Y5 Years-125.9%+35.3%+15.8%

LEGN EBIT Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+32.4%-98.2%+69.9%at high+62.2%
5Y5-Year-125.9%+32.4%-98.2%+69.9%at high+62.2%
All-TimeAll-Time-2346.4%+32.4%-251.1%+69.9%-1475.3%+62.2%

LEGN EBIT History

DateAnnualQuarterlyTTM
Sep 2025
-
-$43.51M(-98.1%)
-$195.21M(+12.1%)
Jun 2025
-
-$21.96M(+56.6%)
-$222.06M(+8.3%)
Mar 2025
-
-$50.65M(+36.0%)
-$242.07M(+21.7%)
Dec 2024
-$309.57M(+30.0%)
-$79.10M(-12.4%)
-$309.29M(+11.9%)
Sep 2024
-
-$70.36M(-67.6%)
-$351.24M(+5.9%)
Jun 2024
-
-$41.97M(+64.4%)
-$373.41M(+14.3%)
Mar 2024
-
-$117.86M(+2.6%)
-$435.75M(+1.5%)
Dec 2023
-$442.22M(+3.5%)
-$121.05M(-30.8%)
-$442.22M(+1.7%)
Sep 2023
-
-$92.52M(+11.3%)
-$449.75M(+10.4%)
Jun 2023
-
-$104.31M(+16.1%)
-$501.94M(+2.9%)
Mar 2023
-
-$124.33M(+3.3%)
-$516.91M(-12.8%)
Dec 2022
-$458.05M
-$128.59M(+11.1%)
-$458.05M(-2.5%)
Sep 2022
-
-$144.71M(-21.3%)
-$446.92M(-14.9%)
Jun 2022
-
-$119.28M(-82.2%)
-$388.98M(-8.4%)
DateAnnualQuarterlyTTM
Mar 2022
-
-$65.47M(+44.3%)
-$358.95M(+7.2%)
Dec 2021
-$394.00M(-71.1%)
-$117.46M(-35.4%)
-$386.74M(-17.6%)
Sep 2021
-
-$86.77M(+2.8%)
-$328.96M(-6.3%)
Jun 2021
-
-$89.25M(+4.3%)
-$309.43M(-12.0%)
Mar 2021
-
-$93.25M(-56.2%)
-$276.20M(-20.4%)
Dec 2020
-$230.27M(-68.0%)
-$59.69M(+11.2%)
-$229.38M(+1.0%)
Sep 2020
-
-$67.23M(-20.0%)
-$231.77M(-18.7%)
Jun 2020
-
-$56.03M(-20.7%)
-$195.23M(-16.5%)
Mar 2020
-
-$46.43M(+25.2%)
-$167.64M(-25.5%)
Dec 2019
-$137.05M(-788.0%)
-$62.07M(-102.2%)
-$133.60M(-86.8%)
Sep 2019
-
-$30.70M(-7.9%)
-$71.53M(-75.2%)
Jun 2019
-
-$28.45M(-129.6%)
-$40.84M(-229.6%)
Mar 2019
-
-$12.39M
-$12.39M
Dec 2018
-$15.43M(-212.0%)
-
-
Dec 2017
$13.78M
-
-

FAQ

  • What is Legend Biotech Corporation annual earnings before interest & taxes?
  • What is the all-time high annual EBIT for Legend Biotech Corporation?
  • What is Legend Biotech Corporation annual EBIT year-on-year change?
  • What is Legend Biotech Corporation quarterly earnings before interest & taxes?
  • What is the all-time high quarterly EBIT for Legend Biotech Corporation?
  • What is Legend Biotech Corporation quarterly EBIT year-on-year change?
  • What is Legend Biotech Corporation TTM earnings before interest & taxes?
  • What is the all-time high TTM EBIT for Legend Biotech Corporation?
  • What is Legend Biotech Corporation TTM EBIT year-on-year change?

What is Legend Biotech Corporation annual earnings before interest & taxes?

The current annual EBIT of LEGN is -$309.57M

What is the all-time high annual EBIT for Legend Biotech Corporation?

Legend Biotech Corporation all-time high annual earnings before interest & taxes is $13.78M

What is Legend Biotech Corporation annual EBIT year-on-year change?

Over the past year, LEGN annual earnings before interest & taxes has changed by +$132.65M (+30.00%)

What is Legend Biotech Corporation quarterly earnings before interest & taxes?

The current quarterly EBIT of LEGN is -$43.51M

What is the all-time high quarterly EBIT for Legend Biotech Corporation?

Legend Biotech Corporation all-time high quarterly earnings before interest & taxes is -$12.39M

What is Legend Biotech Corporation quarterly EBIT year-on-year change?

Over the past year, LEGN quarterly earnings before interest & taxes has changed by +$26.85M (+38.16%)

What is Legend Biotech Corporation TTM earnings before interest & taxes?

The current TTM EBIT of LEGN is -$195.21M

What is the all-time high TTM EBIT for Legend Biotech Corporation?

Legend Biotech Corporation all-time high TTM earnings before interest & taxes is -$12.39M

What is Legend Biotech Corporation TTM EBIT year-on-year change?

Over the past year, LEGN TTM earnings before interest & taxes has changed by +$156.03M (+44.42%)
On this page